The European Pharmaceutical Wholesale Industry: - phagro
The European Pharmaceutical Wholesale Industry: - phagro
The European Pharmaceutical Wholesale Industry: - phagro
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>The</strong> <strong>European</strong> <strong>Pharmaceutical</strong> <strong>Wholesale</strong> <strong>Industry</strong><br />
G: Development of full-line <strong>Wholesale</strong>rs’ Productivity, 2000-2004<br />
2500 Thousand EUR<br />
2000<br />
1500<br />
1000<br />
500<br />
2000 2001 2002 2003 2004<br />
AUT ESP FR GER<br />
GER IT NL UK EU-15<br />
Source: GIRP data, IPF research<br />
UK, UK,GER UK, GER<br />
EU-15, FR<br />
ESP<br />
IT<br />
AUT<br />
� On a macroeconomic perspective, the use of intermediaries enhances efficiency<br />
in the pharmaceutical distribution chain by limiting the number of<br />
transactions necessary to secure a fast and continuous supply of medicines.<br />
In 2004 the number of delivery-transactions amounted to 28 billion. Without<br />
pharmaceutical wholesalers, this number would increase dramatically to unconceivable<br />
528 billion transactions a year.<br />
New Business Models: Services creating Added Value<br />
� Tough competition forced wholesalers to reorganize processes, cut cost and<br />
introduce new business models, improving the branch’s efficiency and competitiveness.<br />
H: Service Spectrum provided by <strong>Pharmaceutical</strong> <strong>Wholesale</strong>rs<br />
Services<br />
creating<br />
added value<br />
Additional services offered<br />
independently from basic<br />
services<br />
Mandatory secondary services<br />
Quality standards Delivery requirements<br />
Primary services<br />
Bridging function Quantity function<br />
Source: IPF<br />
IPF Institute for Pharmaeconomic Research VI<br />
NL
Change language